{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"60","upperLimit":"82","value":"71.7"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"53"}],"units":"Participants"}],"description":"Percentage of participants with complete clinical response. Complete clinical response is defined as no clinical/radiographic evidence of primary disease (vulva or groin) following primary chemo-radiation therapy.","dispersionType":"90% Confidence Interval","groups":[{"description":"Gemcitabine 50 mg/m2 and Cisplatin 40mg/m2 administered weekly throughout IMRT radiation therapy. Gemcitabine will be infused prior to cisplatin and given over approximately 30 minutes while the cisplatin will be delivered over approximately 60 minutes.","id":"OG000","title":"GEM+CIS+IMRT"}],"paramType":"NUMBER","populationDescription":"Eligible and Treated","reportingStatus":"POSTED","timeFrame":"6-8 weeks after completion of chemo-radiation","title":"Complete Clinical Response","type":"SECONDARY","unitOfMeasure":"percentage of participants"}